Tolga Tanguler
Evp, Chief Commercial Officer at Alnylam Pharmaceuticals, Inc. (ALNY)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.1M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 6SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 10636,500 held (−0%) | $319.03 | $34K | -27.1% |
| Mar 6SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 10236,398 held (−0%) | $320.01 | $33K | -27.3% |
| Mar 6SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 21536,183 held (−1%) | $320.81 | $69K | -27.5% |
| Mar 6SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 28935,894 held (−1%) | $321.82 | $93K | -27.7% |
| Mar 6SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 35035,544 held (−1%) | $323.01 | $113K | -28.0% |
| Mar 6SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 76734,777 held (−2%) | $323.84 | $248K | -28.1% |
| Mar 6SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 27234,505 held (−1%) | $324.88 | $88K | -28.4% |
| Mar 6SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 20834,297 held (−1%) | $325.67 | $68K | -28.6% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 4738,157 held (−0%) | $323.62 | $15K | -28.1% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 9038,067 held (−0%) | $324.65 | $29K | -28.3% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 25837,809 held (−1%) | $325.63 | $84K | -28.5% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 39237,417 held (−1%) | $326.81 | $128K | -28.8% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 32937,088 held (−1%) | $327.67 | $108K | -29.0% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 10036,988 held (−0%) | $328.71 | $33K | -29.2% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 17036,818 held (−0%) | $329.71 | $56K | -29.4% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 8136,737 held (−0%) | $330.85 | $27K | -29.7% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 9436,643 held (−0%) | $331.93 | $31K | -29.9% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 3736,606 held (−0%) | $332.64 | $12K | -30.1% |
| Feb 17SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 1,95931,769 held (−6%) | $310.08 | $607K | -25.0% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 3931,199 held (−0%) | $353.95 | $14K | -34.3% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 4231,157 held (−0%) | $355.16 | $15K | -34.5% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 4131,116 held (−0%) | $356.09 | $15K | -34.7% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 9631,020 held (−0%) | $357.17 | $34K | -34.9% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 12330,897 held (−0%) | $358.18 | $44K | -35.0% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 8530,812 held (−0%) | $359.14 | $31K | -35.2% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 15530,657 held (−1%) | $360.22 | $56K | -35.4% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 9830,559 held (−0%) | $361.45 | $35K | -35.6% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 7330,486 held (−0%) | $362.38 | $26K | -35.8% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 4730,439 held (−0%) | $363.55 | $17K | -36.0% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 19930,240 held (−1%) | $364.83 | $73K | -36.2% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 22030,020 held (−1%) | $365.56 | $80K | -36.3% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 5029,970 held (−0%) | $366.41 | $18K | -36.5% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 4129,929 held (−0%) | $367.40 | $15K | -36.7% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 9229,837 held (−0%) | $368.62 | $34K | -36.9% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 4029,797 held (−0%) | $369.48 | $15K | -37.0% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 1929,778 held (−0%) | $370.87 | $7K | -37.3% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 229,776 held (−0%) | $372.46 | $745 | -37.5% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 1429,762 held (−0%) | $374.44 | $5K | -37.9% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 1929,743 held (−0%) | $375.65 | $7K | -38.1% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 1529,728 held (−0%) | $377.82 | $6K | -38.4% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 5528,788 held (−0%) | $446.53 | $25K | -47.9% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 2728,761 held (−0%) | $447.92 | $12K | -48.1% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 8628,675 held (−0%) | $448.77 | $39K | -48.2% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 11928,556 held (−0%) | $449.79 | $54K | -48.3% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 26028,296 held (−1%) | $450.81 | $117K | -48.4% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 15928,137 held (−1%) | $451.86 | $72K | -48.5% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 31927,818 held (−1%) | $452.69 | $144K | -48.6% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 15727,661 held (−1%) | $453.77 | $71K | -48.7% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 11727,544 held (−0%) | $454.84 | $53K | -48.8% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 3527,509 held (−0%) | $455.82 | $16K | -49.0% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 7027,439 held (−0%) | $457.43 | $32K | -49.1% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 127,438 held (−0%) | $457.64 | $458 | -49.2% |